BeOne Medicines (BEIGF) Gross Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | -178.00 |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 532.00 |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 30.00 |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 455.00 |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -233.00 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 565.00 |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 89.00 |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | -196.00 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 589.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 589.00 |
| Mar 31, 2026 | 722.00 |
| Dec 31, 2025 | 984.00 |
| Sep 30, 2025 | 583.00 |
| Jun 30, 2025 | 832.00 |
| Mar 31, 2025 | 651.00 |
| Dec 31, 2024 | 845.00 |
| Sep 30, 2024 | 595.00 |
| Jun 30, 2024 | 931.00 |
| Mar 31, 2024 | -1,123.00 |
| Dec 31, 2023 | 437.00 |
| Sep 30, 2023 | 1,087.00 |
| Jun 30, 2023 | 567.00 |
| Mar 31, 2023 | 891.00 |
| Dec 31, 2022 | 1,227.00 |
| Sep 30, 2022 | 2,035.00 |
| Jun 30, 2022 | -1,351.00 |
| Mar 31, 2022 | -167.00 |
| Dec 31, 2021 | -702.00 |
| Sep 30, 2021 | -690.00 |